Department of Medical Education and Clinical Sciences, Elson S. Floyd College of Medicine, Washington State University, Spokane, Washington.
Department of Epidemiology and Biostatistics, College of Human Medicine, Michigan State University, East Lansing, Michigan.
Am J Addict. 2019 Nov;28(6):465-472. doi: 10.1111/ajad.12943. Epub 2019 Sep 5.
Among newly incident cannabis users, fewer than 4% develop cannabis dependence syndromes within 12 to 24 months, but earlier cannabis side effect (SE) incidence and early syndrome formation remains understudied. We estimate cannabis SE incidence within ~1 to 90 days after first use, and estimate odds ratios (OR) for SE pairs to quantify potential syndromic "running together."
Each year, 2004 to 2014, the US populations under study consisted of noninstitutionalized civilian residents age 12-years-and-older, sampled for National Surveys on Drug Use and Health. Computerized self-interviews identified 3710 newly incident cannabis users and asked about SEs. Analysis-weighted year-specific SE and SE-SE pair incidence proportions were estimated. Analysis-weighted odds ratio (OR) estimates quantify SE-SE co-occurrences, judged as "greater than chance" when lower bounds (LB) of 95% confidence intervals (CIs) exceed 1.0. Meta-analysis is used to summarize and to check reproducibility.
Illustrative of estimates on 17 SEs, roughly 1/2 of cannabis initiates experienced "wanting or trying to cut down or stop using," but 80% of these cut back, such that less than 7% had symptom-like inability to cut back or stop. An estimated 25% had "spent a lot of time getting or using cannabis." The SE-SE paired estimate is 2.8% for those who had spent a lot of time and also had wanted/tried to cut down (95% CI = 2.0, 4.0). OR estimation suggests no syndromic co-occurrence of this SE-SE pair (OR = 0.9; 95% CI = 0.5, 1.6). In contrast, "cannabis causing serious problems at home/work/school" and "continuing to use despite physical problems" were more rare, but had strong SE-SE co-occurrence (OR = 14.8, LB = 2.4). For 78 of 136 possible SE-SE pairs, meta-analysis LB estimates exceeded the 1.0 threshold.
In these US community samples of cannabis initiates studied soon after first use, the vast majority were free of individual SE experiences counted toward Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition cannabis use disorder diagnoses. For a minority, SE-SE pairs might indicate syndrome formation. These epidemiological meta-analysis estimates might find use in refinement of clinical practice guidelines for fast effective syndrome screens when primary care patients are seen soon after cannabis onset, akin to clinical screening guides designed for newly incident drinkers (Am J Addict 2019;00:1-9).
在新出现的大麻使用者中,不到 4%的人在 12 至 24 个月内出现大麻依赖综合征,但早期大麻副作用(SE)的发生和早期综合征的形成仍有待研究。我们估计首次使用后约 1 至 90 天内大麻 SE 的发生率,并估计 SE 对的比值比(OR),以量化潜在的综合征“共同出现”。
每年(2004 年至 2014 年),研究中的美国人群由年龄在 12 岁及以上的非机构化平民居民组成,抽样参加国家药物使用和健康调查。计算机化的自我访谈确定了 3710 名新出现的大麻使用者,并询问了 SE 情况。估计了分析加权的特定年份 SE 和 SE-SE 对发生率比例。分析加权的 OR 估计量化了 SE-SE 的共同发生,当 95%置信区间(CI)的下限(LB)超过 1.0 时,判断为“大于偶然”。荟萃分析用于总结和检查重现性。
以 17 个 SE 中的一个为例,大约有一半的大麻使用者经历过“想要或试图减少或停止使用”,但 80%的人减少了使用,因此只有不到 7%的人出现类似症状,无法减少或停止使用。大约有 25%的人“花了很多时间获取或使用大麻”。对于那些花了很多时间并且也想/试图减少使用的人,SE-SE 配对的估计值为 2.8%(95%CI=2.0, 4.0)。OR 估计表明这种 SE-SE 对没有综合征共同发生(OR=0.9; 95%CI=0.5, 1.6)。相比之下,“大麻在家庭/工作/学校造成严重问题”和“尽管有身体问题仍继续使用”更为罕见,但具有很强的 SE-SE 共同发生(OR=14.8,LB=2.4)。对于 136 个 SE-SE 对中的 78 对,荟萃分析的 LB 估计值超过了 1.0 阈值。
在这些美国社区大麻使用者样本中,他们在首次使用后不久就进行了研究,绝大多数人没有出现符合《精神障碍诊断与统计手册》第四版大麻使用障碍诊断标准的 SE 体验。对于少数人来说,SE-SE 对可能表明综合征的形成。这些流行病学荟萃分析估计可能有助于在初级保健患者在大麻发作后不久就诊时,快速有效地进行综合征筛查的临床实践指南的细化,类似于为新出现的饮酒者设计的临床筛查指南(Am J Addict 2019;00:1-9)。